Cartilage-Derived Angiogenesis Inhibitory Factor
Cartilage-Derived Angiogenesis Inhibitory Factor (CDAIF) is a protein that is known to inhibit angiogenesis, the process through which new blood vessels form from pre-existing vessels. This factor is derived from cartilage, a resilient and smooth elastic tissue, a rubber-like padding that covers and protects the ends of long bones at the joints.
Function[edit | edit source]
CDAIF functions as an angiogenesis inhibitor, a substance that inhibits the growth of new blood vessels (angiogenesis). It is part of the body's mechanism to control the growth and development of blood vessels. This function is crucial in various physiological and pathological processes such as embryogenesis, tissue repair, tumor growth, and inflammatory diseases.
Role in Disease[edit | edit source]
The role of CDAIF in disease is complex. It is involved in various pathological conditions where angiogenesis is a critical factor. For instance, in cancer, the growth and spread of tumors often depend on angiogenesis. Therefore, CDAIF, as an angiogenesis inhibitor, can potentially be used in cancer therapy. Similarly, in rheumatoid arthritis, a disease characterized by inflammation and new blood vessel formation, CDAIF may have therapeutic potential.
Research and Therapeutic Potential[edit | edit source]
Research on CDAIF is ongoing, with scientists exploring its potential therapeutic applications. Given its role in inhibiting angiogenesis, it is being studied for its potential use in treating diseases characterized by excessive angiogenesis, such as cancer and certain eye diseases like macular degeneration.
See Also[edit | edit source]
 | This protein-related article is a stub. You can help WikiMD by expanding it. |
This cartilage-related article is a stub. You can help WikiMD by expanding it.
 | This oncology article is a stub. You can help WikiMD by expanding it. |
This arthritis-related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
